Renato D. Lópes

机构：Alnylam Pharmaceuticals (United States), Duke University, Clinical Research Institute, Duke Medical Center, University of Glasgow, Universidade Federal de São Paulo · ORCID：0000-0003-2999-4961

发表论文 1241 篇 · 总被引 67390 次 · h-index 117

代表论文

Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEO-MINDSET trial (2025 · European Heart Journal · 被引 12)
IVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions (2026 · JACC: Cardiovascular Interventions · 被引 9)
Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease (2025 · JAMA · 被引 8)
Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease (2025 · Journal of the American College of Cardiology · 被引 4)
Prevalence and factors associated with cardiometabolic multimorbidity: a cross-sectional study in older adults of the first Brazilian hypertension registry (2025 · BMC Cardiovascular Disorders · 被引 3)
Utility of biomarkers in patients with a type 2 myocardial infarction: a systematic review (2026 · Open Heart · 被引 2)